Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02370498 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) |
| First Submitted : | February 23, 2015 |
| First Submitted that Met QC Criteria : | February 23, 2015 |
| First Posted : | February 25, 2015 (Estimate) |
| Results First Submitted : | October 22, 2018 |
| Results First Submitted that Met QC Criteria : | October 22, 2018 |
| Results First Posted : | November 20, 2018 |
| Last Update Submitted that Met QC Criteria : | May 12, 2022 |
| Last Update Posted : | June 6, 2022 |